BackTrevi Therapeutics Overview
Trevi Therapeutics Inc

Trevi Therapeutics Target Price

Where could TRVI trade next? Consensus target price: $28.

Get informed when a big investor buys or sells

+ Follow

Share Price

$17.26

Average Target Price

$28.2963.9% upside

7 analysts in the last 4 months

High: $40 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-07Morgan Stanley$2333.3% upsideOpen
2026-08-07Oppenheimer$2544.8% upsideOpen
2026-08-07Raymond JamesRyan Deschner$40131.7% upsideOpen
2026-07-20BMO Capital$36108.6% upsideOpen
2026-07-20H.C. WainwrightBrandon Folkes$2439% upsideOpen
2026-05-08Stifel NicolausAnnabel Samimy$3073.8% upsideOpen
2026-05-06Morgan Stanley$2015.9% upsideOpen
2025-12-19Stifel Nicolaus$184.3% upsideOpen
2025-11-19Leerink PartnersRoanna Ruiz$167.3% downsideOpen
2025-11-14Morgan StanleyJudah Frommer$1910.1% upsideOpen
2025-11-14OppenheimerLeland Gershall$2439% upsideOpen
2024-10-22H.C. WainwrightOren Livnat$665.2% downsideOpen
2024-10-04B.Riley FinancialMayank Mamtani$665.2% downsideOpen
2022-07-09OppenheimerLeland Gershall$1230.5% downsideOpen

Trevi Therapeutics (TRVI) FAQ

The latest target price for TRVI is $28. Investors often review this figure alongside Trevi Therapeutics's historical trend and sector peers before judging valuation or financial health.

Trevi Therapeutics trades near $17.26 while the consensus target sits at $28 (63.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting TRVI's target price ($28), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Trevi Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.